4//SEC Filing
Chin Mark 4
Accession 0001209191-23-037405
CIK 0001659323other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:00 PM ET
Size
7.5 KB
Accession
0001209191-23-037405
Insider Transaction Report
Form 4
Chin Mark
Director
Transactions
- Exercise/Conversion
Restricted Share Units
2023-06-15−15,853→ 0 total→ Ordinary Shares (15,853 underlying) - Exercise/Conversion
Ordinary Shares
2023-06-15+15,853→ 18,306 total
Footnotes (3)
- [F1]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F2]On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.
- [F3]On June 15, 2022, the reporting person was granted an award of 15,853 RSUs, which vested in full on June 15, 2023.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001734389
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 5:00 PM ET
- Size
- 7.5 KB